At Texas Clinic, we offer Vivitrol® (naltrexone for extended-release injectable suspension) as part of a comprehensive treatment program for Alcohol Use Disorder (AUD) and Opioid Use Disorder (OUD). Vivitrol® can help prevent relapse and support long-term recovery when combined with counseling and behavioral therapy.
Vivitrol® is a prescription injectable medication approved by the U.S. Food and Drug Administration (FDA) to:
Treat Alcohol Use Disorder (AUD) — after the patient has stopped drinking.
Prevent relapse to opioid dependence — after complete detoxification from opioids.
Vivitrol® is not an opioid, not addictive, and does not cause physical dependence. It is administered as a once-monthly injection by a healthcare professional.
(Sources: FDA, SAMHSA)
Vivitrol® contains naltrexone, an opioid antagonist that blocks opioid receptors in the brain. By doing so, it:
Reduces cravings for alcohol
Blocks the euphoric and sedative effects of opioids
Helps prevent relapse when patients are committed to a full recovery program
To start Vivitrol® for opioid dependence, patients must be completely detoxed—typically at least 7–14 days opioid-free—to avoid sudden and severe withdrawal symptoms.
(Sources: SAMHSA, CDC)
Vivitrol® has not been studied extensively in children and is currently approved only for adults.
(Sources: FDA, SAMHSA, NIH)
Patients and healthcare providers are encouraged to report any side effects to the FDA MedWatch program.
(Sources: FDA, SAMHSA)
At Texas Clinic, Vivitrol® is offered as part of a full recovery plan that includes:
Medication alone is not enough—Vivitrol® works best when paired with therapy and other structured recovery services to address the underlying causes of substance use.
Our dedicated team is here to guide each patient toward a healthier, more stable future.
Vivitrol® is a registered trademark of Alkermes PLC.